Addiction‐Focused Eye Movement Desensitization and Reprocessing Therapy as an Adjunct to Regular Outpatient Treatment for Alcohol Use Disorder: Results From a Randomized Clinical Trial
Background
This study examined the feasibility, safety, and efficacy of addiction‐focused eye movement desensitization and reprocessing (AF‐EMDR) treatment, as an add‐on intervention to treatment as usual (TAU).
Methods
Adult outpatients with alcohol use disorder (AUD) (N = 109) who already received or had just started with TAU (Community Reinforcement Approach) were recruited at 6 outpatient addiction care facilities. They were randomly assigned to either TAU + 7 weekly 90‐minute sessions of AF‐EMDR (N = 55) or TAU‐only (N = 54). Assessments were made at baseline, after AF‐EMDR therapy (+ 8 weeks in the TAU‐only group), and at 1‐ and 6‐month follow‐up. The primary outcomes were changes in drinking behavior as reported by the participant and biomarker indices.
Results
Data were analyzed as intent‐to‐treat with linear mixed models. Additionally, sensitivity analyses were performed. No group or interaction effects were found for any of the outcome variables. Only limited change over time was seen with regard to indices of personal and societal recovery and in some secondary indices of clinical recovery (craving, desire thinking, and rumination). Reliable Change Index calculations showed that more TAU‐only participants showed clinical improvement with regard to alcohol consumption while a somewhat higher proportion of participants in the TAU + AF‐EMDR group experienced less craving. The acceptability, safety, and feasibility of the treatments received in both groups were comparable.
Conclusions
There was no add‐on effect of AF‐EMDR on TAU with regard to drinking behavior in outpatients with an AUD. Possible explanations are discussed. Future studies should first establish proof of principle regarding the potential of AF‐EMDR therapy to disrupt operant learning and habits relevant in addiction.
Top-30
Journals
|
1
2
|
|
|
Frontiers in Psychiatry
2 publications, 13.33%
|
|
|
Frontiers in Psychology
1 publication, 6.67%
|
|
|
Frontiers in Medicine
1 publication, 6.67%
|
|
|
Psychotropes
1 publication, 6.67%
|
|
|
Journal of Evidence-Based Social Work
1 publication, 6.67%
|
|
|
Cell Reports
1 publication, 6.67%
|
|
|
Brain Sciences
1 publication, 6.67%
|
|
|
STAR Protocols
1 publication, 6.67%
|
|
|
Addictive Behaviors
1 publication, 6.67%
|
|
|
Journal of EMDR Practice and Research
1 publication, 6.67%
|
|
|
Administration and Policy in Mental Health and Mental Health Services Research
1 publication, 6.67%
|
|
|
European Journal of Psychotraumatology
1 publication, 6.67%
|
|
|
1
2
|
Publishers
|
1
2
3
4
|
|
|
Frontiers Media S.A.
4 publications, 26.67%
|
|
|
Elsevier
3 publications, 20%
|
|
|
CAIRN
2 publications, 13.33%
|
|
|
Taylor & Francis
2 publications, 13.33%
|
|
|
Research Square Platform LLC
1 publication, 6.67%
|
|
|
MDPI
1 publication, 6.67%
|
|
|
Springer Publishing Company
1 publication, 6.67%
|
|
|
Springer Nature
1 publication, 6.67%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.